Insta
ICMR, National Institute Of Virology Join Hands With Hyderabad Based Biotech Firm To Develop COVID-19 Vaccine
ICMR Logo
The Indian Council of Medical Research (ICMR) and Pune based National Institute of Virology (NIV) have joined forces with leading vaccine manufacturer Bharat Biotech International Limited (BBIL) to develop an indigenous vaccine effective against COVID-19 disease, reports Times of India.
The combine would together use the strain of COVID-19 virus which was successfully isolated by NIV. The strain has already been transferred from NIV to BBIL's facility in Hyderabad which is the only company in the developing world to boast of having a biosafety level-3.
BBIL is known for having developed 10 different viral vaccines and has in the past delivered over five billion doses of these.
Recently, BBIL has also received the approval from the Council of Scientific and Industrial Research (CSIR) to develop human monoclonal antibodies to treat COVID-19 which would facilitate therapeutic treatment of COVID-19 wherein the antibodies developed would bind themselves to the virus cells and neutralise them.
BBIL's chairman and managing director Dr Krishna Ella has expressed pride in the company's partnership with ICMR and NIV in this project of national importance and said, "We will do everything to make this programme successful in our national endeavour to combat COVID-19 pandemic."
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest
